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Rett syndrome (RTT) patients experience learning difficulties and memory loss.
Analogous deficits of hippocampal plasticity are reported in mouse models of RTT.
To elucidate the underlying pathophysiology, we studied long term potentiation (LTP)
at the CA3 to CA1 synapses in the hippocampus in acute brain slices from WT and
Mecp2−/y mice, by either activating cAMP dependent pathway or using high frequency
stimulation, by means of patch clamp. We have observed that, the NMDA channel
current characteristics remain unchanged in the Mecp2−/y mice. The adenylyl cyclase
(AC) agonist forskolin evoked a long lasting potentiation of evoked EPSCs in WT CA1
neurons, but only minimally enhanced the EPSCs in the Mecp2−/y mice. This weaker
potentiation in Mecp2−/y mice was ameliorated by application of phosphodiesterase
4 inhibitor rolipram. The hyperpolarization activated cyclic nucleotide gated channel
current (Ih) was potentiated to similar extent by forskolin in both phenotypes. Multiple
tetanus induced cAMP-dependent plasticity was also impaired in the Mecp2−/y mice,
and was also partially rescued by rolipram. Western blot analysis of CA region of
Mecp2−/y mice hippocampus revealed more than twofold up-regulation of protein
kinase A (PKA) regulatory subunits, while the expression of the catalytic subunit
remained unchanged. We hypothesize that the overexpressed PKA regulatory subunits
buffer cAMP and restrict the PKA mediated phosphorylation of target proteins necessary
for LTP. Blocking the degradation of cAMP, thereby saturating the regulatory subunits
alleviated this defect.
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INTRODUCTION
Patients with Rett syndrome (RTT) have severe mental retardation. Amir et al. (1999)
discovered that the majority of RTT cases result from mutations in the X-linked
MECP2 (methyl-CpG-binding protein 2) gene richly expressed in the neurons. The Mecp2
protein binds to methylated cytosine on the genomic DNA through a methyl-CpG-
binding domain (MBD) crucial to the gene’s function (Shahbazian et al., 2002; Zhao
et al., 2015). The primary function of Mecp2 is thought to be the repression of gene
transcription, although, it can also act as a transcriptional activator (Chahrour et al., 2008).
Intact Mecp2 function is pivotal to the normal development of nervous system and
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its absence or mutation can lead to defective dendritic structure,
synapse formation and decreased size of the neurons (Gao et al.,
2015; Rietveld et al., 2015).
A mouse model for RTT, which shows typical symptoms of
the disease, was developed by deletion of the MECP2 gene. Male
mice (Mecp2−/y) are preferred over female mice for experiments,
due to the ubiquitous lack of Mecp2 and similar etiology in
individual male mice. The disease phenotype in male mice
manifests at approximately 4 weeks of age. Reduced cognitive
ability of RTT patients is mirrored in the Mecp2−/y mice by the
lack of neuronal network modulation such as LTP that underlie
learning and memory (Moretti et al., 2006). Asaka et al. (2006)
have proposed that a cause for this is the impairment of NMDA
receptor function due to a switch of the NR2A to NR2B subunits.
In addition, Weng et al. (2011) have described a saturation of LTP
in a RTT mouse model, which could be reversed by the NMDA
antagonist Memantine.
cAMP synthesis is essential for inducing and maintaining LTP
in hippocampal CA1 neurons (Huang et al., 1994; Otmakhova
et al., 2000; Otmakhov et al., 2004). The drugs raising cAMP levels
can modulate glutamatergic neurotransmission (Greengard et al.,
1991) and evoke LTP (Frey et al., 1993; Nguyen et al., 1994; Huang
and Kandel, 1995; Bolshakov et al., 1997). In addition, it is shown
that inhibition of AC or PKA by antagonists, decrease tetanic
stimulation induced LTP in the CA1 neurons (Frey et al., 1993;
Otmakhova et al., 2000). Besides, the mice carrying mutated AC I
and VIII exhibit deterioration of long termmemory (Wong et al.,
1999).
It is unknown whether the lack of LTP in Mecp2−/y mouse
is due to a malfunction of the cAMP pathway, and if, AC-PKA
mediated neuronal plasticity is aﬀected in RTT. An indication
was deduced from brainstem neurons of the Mecp2−/y mouse,
that they show a reduced cAMP elevation in response to forskolin
and cytosolic calcium elevation (Mironov et al., 2011). Therefore,
we focused on the role of diﬀerent enzymes in the cAMP signal
pathway with regard to synaptic plasticity in the Mecp2−/y mice
and age matched wild type. Our results show that LTP mediated
by adenylyl cyclase pathway is defective in the Mecp2−/y mouse
due to the uncoupling of downstream signaling by PKA.
MATERIALS AND METHODS
Preparation of Brain Slices
Heterozygous femaleMecp2 gene knockout mice, [B6.129P2(C)-
Mecp2tm−1−1Bird (Guy et al., 2001)] were obtained from Jackson
Laboratories (Bar Harbor, ME, USA) and crossbred with
wild type C57BL/6J males. Symptomatic hemizygous males
(Mecp2−/y) and the male wild type littermate (Mecp2+/y) were
used for the experiments during the 6th week of life. All
animals were used in accordance with the recommendations
of the European Commission (No. L358, ISSN 0378-6978),
and experimental procedures were approved by the Committee
for Animal Research, Gottingen University. The mice were
housed (4–5 littermates per cage) on a 12 h light/dark cycle.
For slice preparation, the animals were anesthetized with
isoﬂurane and the brains were quickly immersed in ice cold
buﬀer containing (mM) 110 choline chloride, 25 NaHCO3,
25 D-glucose, 11.6 Sodium ascorbate, 7 MgSO4, 3.1 sodium
pyruvate, 2.5 KCl, 1.25 NaH2PO4, and 0.5 CaCl2 (Shepherd and
Svoboda, 2005). Coronal slices (350 μm thickness) of whole
brain containing the hippocampus were prepared using Leica
VT 1200s Vibroslicer and were stored in artiﬁcial cerebrospinal
ﬂuid (ACSF) containing (mM): NaCl (126), KCl (3), NaH2PO4
(1.2), NaHCO3 (25), glucose (15), MgSO4 (2), and CaCl2 (2)
and continuously bubbled with carbogen (95% O2, 5% CO2).
The slices were allowed to recover from the slicing procedure
for 1 h at room temperature. Afterward they were transferred
to a submerged chamber under an upright microscope and
superfused with ACSF (ﬂow rate of 2–3 ml/min) at room
temperature.
Electrophysiology
Patch Clamp
Hippocampal CA1 pyramidal neurons were visually identiﬁed
under an upright microscope (BX51, Olympus Optical) with a
40X water-immersion objective that was equipped with infrared
diﬀerential interference contrast (IR DIC) illumination. Neurons
were patch clamped with pipettes of 3–4 M resistance, when
ﬁlled with a solution containing (mM): K-gluconate (110), KCl
(5), HEPES (50), EGTA (0.005), MgSO4 (4), ATP (4), GTP
(0.2), phosphocreatine (9), and pH to 7.4 with 1 M KOH.
Whole cell current recordings were made with the EPC-10
ampliﬁer (HEKA Elektronik, Germany). The series resistance
ranged from 10 to 20 M and was not compensated. Recordings
showing more than 10% ﬂuctuation in series resistance were
discarded from the analysis. Currents were acquired at 10–
25 kHz and low pass ﬁltered at 2–5 kHz. EPSCs were evoked
by stimulating the Schaﬀer collateral inputs to CA1 neurons
with currents of 10–120 μA, using extracellular Teﬂon coated
platinum electrode and square pulse stimulator equipped with
isolated constant current unit (Grass technologies, USA). EPSC
amplitudes were measured at a holding potential (Vh) of−70mV
unless speciﬁed.
Measurement of Long Term Potentiation (LTP)
Fifty micromolar forskolin was applied to evoke EPSC
potentiation. Alternatively, LTP was evoked by three 1 s
long pulse trains at 100 Hz (0.1 ms pulse width), combined with a
switch of the Vh to −10mV, separated by a 10 min inter-stimulus
interval. A 10 min baseline was obtained before the application
of LTP inducing protocols. The extend of the potentiation was
measured at the end of the experiment, in comparison to the
baseline amplitude. Stimulation intensity was adjusted to evoke
similar baseline EPSC amplitudes in WT andMecp2−/y.
Measurement of Ih and NMDA Currents
Ih currents were measured in response to a hyperpolarizing
voltage step from −70 to −140 mV in ‘isolation buﬀer’
as described in Bickmeyer et al. (2002). Ih amplitude was
measured at the end of this voltage step. A Cesium based
intracellular solution with the following composition (in mM)
was used for the measurement of NMDA currents: CsMeSO3
(120), NaCl (2.8), HEPES (10), Tetraethyl ammonium chloride
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(5), EGTA (0.4), Phosphocreatine (5), NaGTP (0.4), MgATP
(4). 20 μM CNQX (6-Cyano-7-nitroquinoxaline-2, 3-dione),
and 50 μM Picrotoxin were added to inhibit AMPA/Kainate
receptors and GABAA receptors for the recording of NMDA
I–V relationship. To determine the proportion of AMPA and
NMDA components, EPSCs were evoked at –70 mV (AMPA)
and +40 mV (NMDA, in presence of 20 μM CNQX and
50 μMpicrotoxin). AMPA/NMDA current ratio was obtained by
dividing the peak amplitude at a holding potential of −70 mV by
the peak amplitude at+40 mV.
Western Blot Analysis
To analyze the expression of PKA subunits, CA regions of
hippocampus (without dentate gyrus) were collected under visual
control from animals that were not used for experimental
manipulations. Tissue was homogenized in RIPA buﬀer [20 mM
Tris/HCl, pH 7.4, 15 mM NaCl, 10 mM EDTA, 10 mM
Iodacetamide, 1% (v/v) Triton X100, 1% (w/v) Na-Deoxycholate,
0,1% (w/v) SDS] supplemented with a protease inhibitor
cocktail (Sigma). Protein concentration was determined by
Bradford assay and 30 μg of each sample were mixed with
Laemmli buﬀer [20 mM Tris/HCl, pH 6.8, 2 mM EDTA,
2% (w/v) SDS, 10% (v/v) 2-mercaptoethanol, 10% (v/v)
glycerol and 0.3% (w/v) bromophenol blue] and boiled for
5 min at 95◦C. Proteins were separated using 10% SDS–
PAGE and transferred onto a nitrocellulose membrane. The
membrane was blocked with 2% w/v BSA/TBS (pH 7.4) for
30 min at room temperature. The regulatory (#3972, Cell
Signaling Technology) and catalytic (sc-30667, Santa Cruz)
subunits of PKA were detected using respective primary
antibodies (Cell Signaling and Santa Cruz, respectively). The
antibodies did not diﬀerentiate between diﬀerent subclasses
of the subunit types. After washing, appropriate secondary
antibodies (IRDye 680LT and 800CW; LI-COR, Lincoln,
Nebraska, USA) were used at a dilution of 1:10,000 for 2 h
at RT. The visualization of the antigen–antibody reaction was
performed using the Odyssey detection system (LI-COR, Lincoln,
NE, USA). Expression level diﬀerences were determined by
comparing ﬂuorescence intensities between WT and Mecp2−/y
tissue. Statistical signiﬁcance of the expression was tested
independently for regulatory and catalytic subunits by Student’s
t-test using GraphPad Prism v5.0. For display, expression
levels of the regulatory and catalytic subunit of WT were set
to 1.
Protein Kinase A Assay
Hippocampi from both sides were dissected from WT and
Mecp2−/y mice on their 6th week of life. Care was taken to
completely isolate the Ammon’s horn from Dentate Gyrus. Only
the Ammon’s horn was used for the assays. The tissues from
nine WT and eight Mecp2−/y mice were pooled separately.
For protein kinase A (PKA) assay, equal weights (50 mg
per experiment) of WT or Mecp2−/y tissue were separately
homogenized in Teﬂon coated manual homogenizer. Tissue
extracts were assayed for PKA mediated phosphorylation of
PepTag A1 ﬂuorescent peptide and quantiﬁed according to the
protocol outlined by Promega for PepTag Assay (catalog #
V 5340) for cAMP dependent PKA. Phosphorylated peptides
have a net −1 charge and move to the anode whereas non-
phosphorylated peptides retain the +1 charge and move to
the cathode. For quantiﬁcation, respective negatively charged
ﬂuorescent bands of WT and Mecp2−/y were cut out from the
agarose gel (keeping the volume uniform and approximately
250 μl) and transferred to a separate graduated microcentrifuge
tube and heated at 95◦C until the slice is melted. The volume
was made up to 250 μl with distilled water. 175μl each of the
hot agarose was transferred to separate tubes, each containing
75 μl of gel solubilization solution, 100 μl of glacial acetic
acid and 150 μl of distilled water. The mixture was vortexed
and transferred to a 0.5 ml cuvette. The absorbance of the
mixture was measured at 570 nm using a spectrophotometer. The
number of moles of phosphorylated peptide is computed using
Beer’s law and normalized to that of the non-phosphorylated
peptide for WT and Mecp2−/y. The statistical signiﬁcance of
the diﬀerence in phosphorylation activity was tested by Students
t-test.
Drugs
All drugs were purchased from Tocris (Bio-Techne, Germany).
CNQX to block AMPA, Picrotoxin to inhibit GABAA, forskolin
to activate AC, SQ 22536 to block AC and rolipram to inhibit
PDE4 were dissolved in DMSO. Final concentration of DMSO
during the drug applications did not exceed 0.1%.
Analysis
Statistical signiﬁcance of Input-output relation was tested by
ANOVA. EPSC traces shown in the ﬁgures are average of
ﬁve sequential recordings. Stimulus artifacts were truncated for
clarity. Time kinetics of LTP measurements were calculated
from the average of normalized amplitudes of the EPSCs from
individual experiments. Average amplitudes of the EPSCs at
baseline were compared with those obtained at the end of the
experiment to calculate the extent of potentiation. Data are given
in mean ± SEM of 3–7 cells as indicated. Statistical signiﬁcance
of the LTP data was tested by single, two or paired t-test
using Origin 8 (Origin lab, Northampton, USA) or GraphPad
Prism (GraphPad Software Inc., La Jolla, CA, USA). P-value
less than 0.05 was considered signiﬁcant. Power of the sample
sizes (minimum 80%) were calculated using Power calculator
(Statistical solutions LLC).
RESULTS
NMDA Receptor Mediated Current is not
Perturbed in Mecp2−/y Mice
NMDA channel mediated currents play a crucial role in
the induction of neuronal plasticity evoked by both tetanic
stimulation and cAMP pathway activation. Even though Asaka
et al. (2006) proposed that an altered NMDA subunit expression
may underlie the reduced LTP in Mecp2−/y mice, physiological
evidence is lacking whether the NMDA channel conductance
is altered. Therefore, we studied pharmacologically isolated
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NMDA currents in presence of AMPA and GABA receptor
blockers. CA1 neurons were held at varying holding potentials
from −70 to +40 mV and NMDA channel mediated synaptic
currents were evoked by stimulation of Schaﬀer collaterals.
Stimulation intensity was adjusted to obtain similar amplitude
currents at −70 mV in WT and Mecp2−/y mice. As shown
in Figure 1A, the I–V relation of the NMDA currents
was not signiﬁcantly diﬀerent in WT and Mecp2−/y CA1
neurons, neither at negative (at −20 mV: −108.94 ± 28 pA
(WT), −124.42 ± 17pA (Mecp2−/y); n = 5, P = 0.07, paired
sample t-test) nor positive (at +40 mV: 178.31 ± 30 pA (WT),
223.3 ± 18pA (Mecp2−/y); n = 5, P = 0.16, paired sample
t-test) potentials. The AMPA to NMDA ratio of the EPSCs
from WT (1.75 ± 0.03) and Mecp2−/y (1.71 ± 0.05) was also
statistically insigniﬁcant (n = 5, P = 0.06, Figure 1B, paired
sample t-test).
Forskolin Induced Potentiation of EPSCs
is Impaired in the Hippocampus of
Mecp2−/y Mice
Previous ﬁndings show that the extent of electrically induced LTP
is lower in the hippocampus of Mecp2−/y mouse models (Asaka
et al., 2006; Moretti et al., 2006). To evaluate further, we tested
forskolin evoked LTP in the hippocampus of Mecp2−/y mouse
in comparison to WT, through whole cell recordings of EPSCs
in CA1 neurons. Mecp2−/y neurons displayed comparatively
higher input-output relationship to WT neurons [10–40 μA
(n.s), 50 μA (P < 0.05), 60–120 μA (P < 0.01), Figure 2A] as
previously shown (Janc and Müller, 2014). The LTP experiments
are done with a stimulation intensity in the range of 10–
40 μA, a range where there is no signiﬁcant diﬀerence in
the EPSC amplitudes of WT and Mecp2−/y neurons in I/O
ratio. After 10 min of control recordings, 50 μM forskolin
was bath applied to the slices for 15 min to activate AC,
which induced a long-lasting potentiation of EPSC amplitude
(2.91 ± 0.07 times the baseline, n = 8, P < 0.001, single
sample t-test, Figure 2Ba and ﬁlled circles in Figure 2Be) in the
wild type CA1 neurons. This response was completely abolished
by inhibiting AC with 100 μM SQ 22536 (1.02 ± 0.07 times
baseline, n = 4, P = 0.95, single sample t-test, Figure 2Bb
and open circles in Figure 2Be). Application of SQ 22536
(100 μM) alone did not alter the neurotransmission at basal
level stimulation of WT (1.01 ± 0.03 times the baseline,
Supplementary Figure S1A, n = 5, P = 0.13) or Mecp2−/y
(1.07 ± 0.06 times the baseline, Supplementary Figure S1A,
n = 5, P = 0.33). CA1 neurons of Mecp2−/y mice, however,
lacked sustained potentiation of EPSC amplitudes in response
to forskolin (1.38 ± 0.17 times the baseline amplitude, n = 6,
P = 0.06, single sample t-test, Figure 2Bc and ﬁlled red
circles in Figure 2Be). Supplementing forskolin application with
the phosphodiesterase 4 inhibitor rolipram (100 nM), which
is known to facilitate hippocampal LTP (Barad et al., 1998),
enhanced the amplitude of EPSCs signiﬁcantly in Mecp2−/y,
although not to WT levels (1.80 ± 0.10 times the baseline
amplitude, n = 5, single sample t-test P < 0.01, Figure 2Bd
and ﬁlled green circles in Figure 2Be). Perfusion of rolipram
FIGURE 1 | (A) NMDA currents had similar amplitudes in WT (n = 5) and
Mecp2−/y (n = 7) CA1 neurons. The traces show isolated NMDA currents
at −20 mV (inward) and +40 mV (outward) of a WT and Mecp2−/y CA1
neurons. The plot represent the IV curve of normalized (to the WT current
amplitude at +40 mV) NMDA channel currents from WT and Mecp2−/y CA1
neurons evoked at a series of holding potentials from −70 mV to +40 mV in
10 mV steps (filled circles represent WT and open circles denote Mecp2−/y ).
(B) Averaged AMPA to NMDA current ratio of WT and Mecp2−/y CA1
neurons showing no significant difference in the conductance of these
channels between WT and Mecp2−/y . The traces indicate the overlaid AMPA
(inward) and NMDA (outward) currents of WT and Mecp2−/y from a
representative experiment.
(100 nM) alone (without forskolin) did not have signiﬁcant eﬀect
on the amplitude of EPSCs in the WT (0.96 ± 0.1 times the
baseline, Supplementary Figure S1B, n = 5, P = 0.59) and
Mecp2−/y mice (1.10 ± 0.03 times the baseline, Supplementary
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FIGURE 2 | (A) Input–output curve of WT (n = 5) and Mecp2−/y (n = 5) CA1 neurons recorded in response to Schaffer collateral stimulation with increasing current
steps from 10 to 120 μA. Mecp2−/y CA1 neurons were characterized by significantly (P < 0.01) increased current ratio to stimulation intensity from 60 to 120 μA.
The plot shows EPSC amplitudes normalized to WT value at 120 μA. (B) Forskolin enhanced synaptic efficacy in WT but not in Mecp2−/y CA1 neurons.
Representative EPSC traces are shown in (Ba) to (Bd) and the time kinetics of EPSC amplitude from each set of experiments are shown in (Be). Gray traces in (Ba)
to (Bd) are the baseline EPSCs and black traces represent EPSC after respective drug applications. (Ba) The application of 50 μM Forskolin (black horizontal line in
(Be)) evoked evident potentiation of the EPSC amplitude in WT (n = 8) CA1 neurons. (Bb) Addition of adenylyl cyclase inhibitor SQ22536 (100 μM, red horizontal
line in (Be)) 5 min before Forskolin application blocked EPSC potentiation (n = 4). (Bc) Forskolin failed to evoke lasting increase in the amplitudes of EPSCs in
Mecp2−/y mouse (red filled circles in (Be), n = 6) CA1 neurons. (Bd) Forskolin applied in presence of PDE4 inhibitor rolipram (gray bar in B) improved the EPSC
potentiation in Mecp2−/y significantly (green filled circles in (Be), n = 5).
Figure S1B, n = 5, P = 0.22). Moreover, treatment of the
slices with forskolin and rolipram did not signiﬁcantly increase
(P = 0.97, when compared to LTP induced by forskolin
alone, two sample t-test) the LTP further in the WT mice
(2.99 ± 0.08 times the baseline, P < 0.0001, Supplementary
Figure S1C, n = 5). We compared the expression of forskolin
induced LTP in WT and Mecp2−/y, by using same stimulus
intensity (60 μA) to evoke a similar number of presynaptic
inputs. This revealed a diﬀerence in the basal amplitude of
EPSC in WT and Mecp2−/y, whereby Mecp2−/y CA1 neurons
were more excitable than the WT CA1 neurons. Perfusion
of 50 μM forskolin invoked a steady increase in the EPSC
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FIGURE 3 | Forskolin induced enhancement of Ih was similar in CA1 and CA3 neurons from both genotypes. Ih was evoked by a step hyperpolarization
from a holding potential of −70 to −140 mV for 1 s as shown below each trace. (A) Representative Ih traces from WT CA1 neurons, (n = 4) before (gray) and after
(black) forskolin application. (B) Representative Ih traces from Mecp2−/y CA1 neurons (n = 4), before (gray) and after (black) forskolin application. (C) Averaged
current amplitude increase by forskolin in CA1 neurons. (D) Representative Ih traces from WT CA3 neurons (n = 4), before (gray) and after (black) forskolin
application. (E) Representative Ih traces from Mecp2−/y CA3 neurons (n = 4), before (gray) and after (black) forskolin application. (F) Averaged current amplitude
increase by forskolin in CA3 neurons.
amplitude and established an LTP of 3.51 ± 0.22 times the
baseline (n = 5, single sample t-test, P < 0.001, Supplementary
Figure S1D, ﬁlled circles) in the WT neurons. Whereas it
evoked only a potentiation of 1.29 ± 0.29 times the baseline
(n = 5, single sample t-test, P < 0.05) in the Mecp2−/y
mice.
cAMP Synthesis and Action in the
Mecp2−/y Mouse Hippocampus
CA1 and CA3 neurons of mice show an Ih current through
the hyperpolarization activated cyclic nucleotide gated
(HCN) channels (Vasilyev and Barish, 2002). Drugs that
elevate cAMP levels are known to increase the amplitude
of Ih (Gasparini and DiFrancesco, 1999), depolarize the
neurons and enhance neurotransmission (Beaumont and
Zucker, 2000). Therefore, we used Ih current amplitude
(measured at the end of the voltage step) as readout of the
cAMP production (Heine et al., 2002) by forskolin. The
measurements showed that 50 μM forskolin caused an Ih
amplitude increase of 103.37 ± 4.76 pA in the WT and
96.33 ± 7.8415 pA in Mecp2−/y CA1 neurons (Figures 3A–C,
n = 4, P = 0.59, two sample t-test). Similarly the increase in
the Ih amplitude (69.07 ± 3.05pA in WT and 60.99 ± 5.2 pA
in Mecp2−/y) caused by forskolin was not signiﬁcantly diﬀerent
in WT and Mecp2−/y CA3 neurons (Figures 3D–F, n = 4,
P = 0.22, two sample t-test) of WT and Mecp2−/y. Albeit
the diﬀerences were insigniﬁcant, these results show that
forskolin is able to activate AC in the CA1 (postsynaptic)
and the CA3 (presynaptic) neurons in WT and Mecp2−/y
to synthesize cAMP and activate a downstream signal
process.
Rescue of the Multiple Tetanus Induced
cAMP Dependent LTP inMecp2−/y by
PDE4 Blockade
After forskolin induced LTP induction failed in Mecp2−/y
mice, we checked whether strong electrical stimulation is more
successful. Stimulation with multiple (three) tetani was used to
induce the synthesis of cAMP, thereby mediating PKA dependent
long lasting potentiation (Frey et al., 1993; Huang and Kandel,
1994). In our experiments, three 100 Hz pulses, each for 1 s, with
an inter-stimulus interval of 10 min were applied to the Schaﬀer
collateral inputs of the CA1 neurons. This produced a steady
and reproducible LTP for at least 2 h (3.97 ± 0.4 times control
amplitude, n = 5, P < 0.001, single sample t-test, Figure 4Aa
and ﬁlled circles in Figure 4B) in the WT. The potentiation was
blocked by the application of adenylyl cyclase inhibitor SQ22536
(100 μM), applied 5 min before the ﬁrst until 5 min after the
third tetanus (1.24 ± 0.07 times baseline n = 3, P = 0.86, single
sample t-test Figure 4Ab and open circles in Figure 4B). In
contrast to the response in WT mice, application of the same
tetanic stimulation protocol did not induce signiﬁcant LTP in the
slices from Mecp2−/y mice (0.97 ± 0.14 times increase, n = 5,
P = 0.08, single sample t-test, Figure 4Ac and ﬁlled red triangles
in Figure 4B).
Previous ﬁndings have shown that the presence of
phosphodiesterase (PDE) inhibitors can strengthen and
prolong tetanus induced LTP in CA1 neurons (Barad et al., 1998;
Navakkode et al., 2004). Hence it was tested whether the blockage
of cAMP degradation during the tetanus could boost the signal
transduction and rescue the defective LTP in Mecp2−/y mouse
CA1 neurons. Perfusion of 100 nM rolipram (from beginning
of the acquisition till 60 min after the third tetanus) resulted in
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FIGURE 4 | Three tetanic pulses separated by 10 min were applied to Schaffer collaterals for 1 s each (represented by the arrows) to evoke cAMP
dependent LTP. Traces from individual experiments are shown in (A) and the averaged EPSC amplitude time course in B. EPSC amplitude modulation in the WT
CA1 neurons is shown in (Aa) (gray trace is control and black is during LTP) and filled circles in (B) (n = 5). Adenylyl cyclase inhibitor SQ 22536 (100 μM) blocked
this effect when applied along with the tetanus (for 30 min), (Ab) (gray trace is control and black is after SQ22536 treatment) and open circles in (B) (n = 3). Same
tetanic stimulation protocol failed to evoke LTP in Mecp2−/y CA1 neurons, (Ac) (gray trace is control and black trace represent the averaged EPSCs∼60 min after
the tetanus) and red filled triangles in (B) (n = 5). Treatment of slices with rolipram (for 60 min starting 5 min before the first tetanus) caused a delayed but steady
increase in the EPSC amplitude of Mecp2−/y CA1 neurons; (Ad) (gray is control and black is during LTP) and green filled triangles in (B) (n = 4).
a modest increase of the EPSC amplitudes in Mecp2−/y CA1
neurons and rescued the LTP to a signiﬁcant level (2.47 ± 0.25
time baseline, n = 4, P < 0.05, single sample t-test, Figure 4Ad
and green ﬁlled triangles in Figure 4B).
Assay of PKA Activity and Expression
Levels
The electrophysiology results indicate that the adenylyl cyclase
function is unimpaired and enhancement of PDE4 activity does
improve forskolin and multiple tetanus induced plasticity in
Mecp2−/y mice. Hence the reduction in LTP may result from
malfunction of a downstream signaling molecule, viz. PKA. As
Mecp2 plays a regulatory role in gene expression, we ﬁrst checked
for the expression of PKA in the CA region of hippocampus. The
expression of PKA in the CA layers of hippocampus was analyzed
by Western Blot using antibodies against both the catalytic and
regulatory subunits of the enzyme. The quantiﬁcation of bands
revealed that, the expression of the regulatory subunits of PKA
in the Mecp2−/y mice (PKAreg) was 2.05 ± 0.28 times higher
than in WT animals (Figures 5A,B, PKAreg, n = 7, Student’s
t-test, P< 0.005). The catalytic subunit (PKAcat) expression levels
remained unchanged (Figures 5A,B, PKAcat, 1.14 ± 0.16, n = 7,
Student’s t-test, P = 0.49,) in theMecp2−/y and WT animals.
Tissue extracts of hippocampus from both phenotypes were
also analyzed for the PKA enzyme activity, with PepTag assay.
The samples were checked for their eﬃciency in phosphorylating
a test peptide provided in the kit. The phosphorylation ability was
quantiﬁed by spectrophotometry. This analysis revealed that the
phosphorylation mediated by PKA in the hippocampal extracts
of WT (0.32 ± 0.04, Figures 5C,D) and Mecp2−/y (0.28 ± 0.02,
Figures 5C,D) of the test peptide was not signiﬁcantly diﬀerent
(Two-sample t-test, P = 0.34). The values are calculated as the
ratios of the number of moles of phosphorylated peptide to the
non-phosphorylated peptide in each lane for both genotypes.
DISCUSSION
The cAMP-dependent pathway mediates molecular signaling for
memory consolidation (Kandel, 2012). Although it is known
that there is LTP defect in RTT (Asaka et al., 2006; Moretti
et al., 2006), the underlying causes have not been thoroughly
evaluated. The results of this study indicate that NMDA channel
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FIGURE 5 | Quantification of PKA subunit expression in hippocampal tissue of WT and Mecp2−/y mice. (A) Normalized protein expression of the
regulatory and catalytic subunit in hippocampal tissue of WT and Mecp2−/y mice show a significant (∗∗P < 0.005) >2-fold upregulation of the regulatory subunits in
Mecp2−/y tissue. (B) Exemplary Western Blot as recorded with the Odyssey system (LI-COR). Samples were run on the same gel and blotted on the same
membrane, but PKA subunits (red) were detected separately with GAPDH (green) used as loading control (n = 7). (C) Analysis of protein kinase A (PKA) activity was
tested as the ability to phosphorylate fluorescent test peptides. electrophoresis of the samples from WT and Mecp2−/y . WT lane indicate the sample where
hippocampal extract from WT animals are added and Mecp2−/y lane indicate the sample with Mecp2−/y hippocampal extract. Con- is the phosphorylated control
and Con+ is the non-phosphorylated control. (D) PKA phosphorylation activity of WT (n = 3) againt Mecp2−/y (n = 3), is calculated from the ratio of absorbance of
phosphorylated bands to that of non-phosphorylated bands at 570 nm.
activity (current/voltage relationship and AMPA/NMDA ratio)
remain unchanged, but the cAMP signaling cascade is defective
in the Mecp2−/y mouse. Our experiments with forskolin show
that direct stimulation of the AC in Mecp2−/y mice is unable
to induce the long lasting enhancement of neuronal currents of
CA1 neurons. Similarly multiple tetani induced LTP was also not
expressed in the Mecp2−/y mice. Both forms of plasticity could
be partially rescued by PDE blocker rolipram.
Direct activation of AC with forskolin is known to enhance
glutamatergic currents in the CA1 neurons and PDE inhibition
is proven to potentiate this eﬀect further (Chavez-Noriega and
Stevens, 1992). The potentiation of EPSC amplitudes elicited
in WT slices shown in Figure 2 is indeed due to AC activity
as the speciﬁc inhibitor SQ 22536 is able to block it. The
absence of forskolin mediated potentiation of EPSCs in the
Mecp2−/y mice could be due to the reduced activation of
AC resulting in lower cAMP synthesis. This was checked by
studying the HCN channel currents (Ih) directly inﬂuenced
by cAMP. Analysis of the eﬃciency of AC stimulation to
modulate Ih current clearly shows that forskolin is able to activate
AC in WT and Mecp2−/y mouse hippocampus equally. This
observation proves that cAMP production in these neurons
was unaltered and cAMP was able to activate a downstream
signaling event. Ih in CA3 neurons (presynaptic) from WT
and Mecp2−/y expressed similar enhancement in response to
forskolin, which conﬁrms that the lack of potentiation in
Mecp2−/y is not due to a non-responsive Ih current. These
observations lead us to conclude that the cAMP synthesis is intact
in Mecp2−/y mouse and downstream signaling pathways to AC
are analyzed.
Protein kinase A is the major eﬀector in the cAMP
signaling cascade, which strengthens the synaptic transmission
by phosphorylation of synaptic proteins (Esteban et al., 2003;
Bonanomi et al., 2005; Menegon et al., 2006). Postsynaptic PKA
activation is speciﬁcally shown to be critical for the development
and maintenance of diﬀerent phases of LTP (Blitzer et al., 1995;
Nguyen and Kandel, 1997; Otmakhova et al., 2000; Duﬀy and
Nguyen, 2003). We suspected that a change in PKA enzyme
function may cause the reduced LTP in Mecp2−/y animals. We
selected CA1/CA3 regions of hippocampus for PKA activity
assay because both presynaptic and postsynaptic PKA activity is
important in modulating synaptic communication. We assayed
for PKA enzyme activity in WT and Mecp2−/y samples, but did
not ﬁnd any signiﬁcant change, which indicates that the defect in
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the forskolin mediated potentiation is not due to non-functional
PKA. Our Western blot data showed only minor changes in
the expression of PKA catalytic subunits in the Mecp2−/y mice,
justifying the result of the PKA activity assay. However, it revealed
a greatly increased expression of the regulatory subunits, which
pointed to an excess of free regulatory PKA subunits in the
cytoplasm. Such abundant free regulatory subunits will bind
cAMP and buﬀer cAMP levels to restrict its availability for
PKA activation. This conclusion is consistent with the reports
that the expression of dominant-negative mutants of cAMP
binding sites in the regulatory PKA subunit, that are insensitive
to cAMP, renders the enzyme functionless (Mellon et al., 1989;
Hammerschmidt et al., 1996; Willis et al., 2011; Yang et al., 2014).
Hence, cAMP-PKA pathway in Mecp2−/y, to be functional,
would require a much larger cAMP level to evoke the same
eﬀect as in WT animals. Such a reduction of PKA activity
would explain the observed defect in the LTP of Mecp2−/y CA1
cells. Additionally, PKA localization near AC is shown to be
critical in determining the PKA activity and its mediation of
LTP at the CA1 region (Kim et al., 2011). cAMP microdomains
are usually restricted around AC by the action of PDEs, and
colocalization of AC and PKA overcomes this restriction and
maximizes the chances of cAMP binding to PKA. We speculate
that an overexpression of the regulatory subunit might disrupt
this arrangement.
Barad et al. (1998) and Navakkode et al. (2004) state that
inhibition PDE4 and enrichment of cAMP life has a positive
eﬀect on the induction and maintenance of tetanus induced LTP.
Similarly, it is shown by Kim et al. (2011) that inhibiting PDE
activity can indeed rescue LTP defect caused by the disruption
of PKA anchoring. Our experiments with rolipram application
prove that the defective LTP in Mecp2−/y animals could be
rescued by cAMP enhancement. This also indicates that the
LTP restrain in Mecp2−/y could result from a lack of cAMP
availability due to buﬀering by upregulated PKA regulatory
subunits. Inhibition of cAMP hydrolysis, thereby increasing the
availability of cAMP, saturated the regulatory subunits and drove
the PKA catalysis eﬃciently. This is also corroborated by the
results on PKA enzyme activity, where a saturating amount of
cAMP could drive the phosphorylation of target proteins in the
tissue extracts from both phenotypes.
CONCLUSION
The above ﬁndings suggest that there are malfunctions of the
cAMP signaling cascade in the Mecp2−/y mice. The expression
of the regulatory subunit of PKA is signiﬁcantly upregulated,
leading to increased buﬀering of cAMP and limiting the catalytic
function of the enzyme. This defect can be attenuated with the
pharmacological enhancement of cAMP availability in the cells by
blocking its degradation with rolipram. Further experiments are
required to uncover additional defective molecular candidates in
the cAMP-PKA signal cascade, eliciting pathophysiology. In vivo
experiments are required to conﬁrm that cAMP enrichment can
indeed ameliorate the memory related symptoms in Mecp2−/y
mice.
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FIGURE S1 | (A) Adenylyl cyclase inhibitor 100 μM SQ 22536 (bar) did not affect
EPSC amplitude (normalized to baseline, n = 5 each) in the WT and Mecp2−/y
CA1 neurons. Inset shows the representative EPSCs during the baseline (gray)
and at the end of the measurement (black) from WT (left) and Mecp2−/y (right).
(B) PDE4 inhibitor rolipram (100 nM) did not evoke EPSC potentiation by itself in
the WT and Mecp2−/y CA1 neurons. Inset traces, WT (left) and Mecp2−/y (right),
represent the EPSCs before (gray) and at the end of the rolipram treatment (black).
The plot shows the EPSC amplitudes normalized to baseline (n = 5). (C)
Supplementing with rolipram (100 nM) did not significantly enhance the forskolin
induced LTP further in the WT CA1 neurons (black filled circles, n = 5,
2.99 ± 0.08 times the baseline; P = 0.97, when compared to LTP induced by
forskolin alone) displayed by the time kinetics of normalized EPSC amplitude in the
graph. The potentiation induced by forskolin in the WT is shown for comparison
(open circles, 2.91 ± 0.07 times the baseline, n = 8). Traces represent the EPSCs
before (gray) and at the end of the experiment. (D) LTP induced by forskolin in WT
and Mecp2−/y CA1 with a stimulus intensity of 60 μA to recruit similar number of
presynaptic inputs. Forskolin application produced evident potentiation in the WT
(filled circles) but was much reduced in the Mecp2−/y (open circles). Inset shows
representative EPSCs from each phenotype.
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